Product Program year 2021 Source: CMS Open Payments

Xience V coronary stent system

Device Vascular

PDI 08717648064470

Open in the dashboard

General payments

$177,177

223 payments

Research payments

$349,573

199 payments

Through program year 2021, $177,177 in general payments and $349,573 in research payments were reported against Xience V coronary stent system (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $177,177 223
2021 Research $349,573 199

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $177,177 223 payments
Top recipients General payments · program year 2021
  1. Saint Lukes Hospital Of Kansas City Teaching hospital · MO $94,300 53% · 1 payment
  2. David Cohen Interventional Cardiology · Roslyn, NY $24,400 14% · 1 payment
  3. Ozgen Dogan Cardiovascular Disease · Brooklyn, NY $16,500 9% · 17 payments
  4. Steven Marx Cardiovascular Disease · New York, NY $14,500 8% · 15 payments
  5. David Engel Cardiovascular Disease · New York, NY $12,000 7% · 12 payments

The top 5 of 98 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $48,276 58% · 24 practitioners
  2. Interventional Cardiology Internal Medicine $30,439 37% · 46 practitioners
  3. Neurology Psychiatry & Neurology $2,000 2% · 1 practitioner
  4. Family Medicine $1,000 1% · 1 practitioner
  5. Internal Medicine $239 <1% · 3 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Missouri $118,703 67% · 3 recipients
  2. New York $49,292 28% · 23 recipients
  3. California $2,252 1% · 3 recipients
  4. Kentucky $2,146 1% · 27 recipients
  5. Pennsylvania $2,000 1% · 1 recipient

The top 5 of 16 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

223 general · 199 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record